Lilly Acquires Centessa to Expand Sleep Disorder Pipeline
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
PR Newswire: press release distribution, targeting, monitoring and marketing2026.03.31Updated 14d ago
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines...
AI SummaryPowered by AI
Eli Lilly is acquiring Centessa Pharmaceuticals in a strategic move to advance its portfolio of sleep-wake disorder treatments. The clinical-stage company brings novel therapeutics that complement Lilly's existing neuroscience pipeline. This acquisition strengthens Lilly's position in the growing sleep medicine market.
Original Article
Read full article on PR Newswire: press release distribution, targeting, monitoring and marketingeli lillycentessa pharmaceuticalssleep-wake disordersneurosciencepharmaceutical acquisitionclinical-stagetherapeuticslillycentessapharmaceuticals
Explore More
Related News
NASA to Host Artemis II Crew Postflight News Conference - NASA
NASA · 2026.04.14
US eyes potential second round of in-person talks with Iran as blockade takes hold | CNN Politics
CNN · 2026.04.14
Embattled GOP Rep. Tony Gonzales announces he’s stepping down from Congress | CNN Politics
CNN · 2026.04.14
JD Vance had a vision for the world. Trump is wrecking it.
Vox · 2026.04.14
US intel officials scramble to keep surveillance law running amid Iran war tensions | CNN Politics
CNN · 2026.04.14
Judges fired after blocking deportation of pro-Palestinian students
The Guardian · 2026.04.14